Universities and research institutes at Festival of Biologics 2026

Oct 13–15, 2026 Basel, Switzerland ~3k attendees Website

64 universities and research institutes are at Festival of Biologics 2026 — 103 presentations on the program. Most represented: ETH Zurich (5 on the program), Technical University of Denmark (4 on the program), Botnar Institute of Immune Engineering (3 on the program). 26 of them have their own page in this guide. As of Sep 26, 2026.

All 378 organizations at Festival of Biologics 2026 →

Showing 1–11 of 64 organizations

Organization	Festival of Biologics 2026 Attendance
ETH Zurich Zurich, Switzerland
	Talk Tue Oct 13 17:50 Title TBA Cell Therapy Chair Wed Oct 14 14:05 Chair's Remarks CMC & Developability Talk Wed Oct 14 15:10 High-Throughput Mechanical Phenotyping of Protein–Protein Interactions A faster way to measure how much pulling force protein pairs can withstand, which can differ from how tightly they bind. Talk Thu Oct 15 12:20 Allogeneic T cells synergising with bispecific antibodies achieve superior Antitumor responses Donor T cells engineered to be activated by two-target antibodies without attacking the patient, tested for stronger anti-tumour responses. Talk Thu Oct 15 12:40 Title TBA Proteomics & Mass Spectrometry
Technical University of Denmark Kongens Lyngby, Denmark
	Talk Tue Oct 13 15:30 Next-generation CHO cell lines for cheaper biosimilar production Upstream Processing Talk Tue Oct 13 17:30 Title TBA Upstream Processing Talk Wed Oct 14 12:10 Insights from Big Data and Novel Platforms to engineer Next Generation of Antibody, Bi-and Multispecific Therapeutics Bispecifics & Multispecifics Talk Wed Oct 14 14:50 Novel platform of glycoengineered sEV for superior drug delivery and gene therapy Gene Therapy Talk Thu Oct 15 11:20 Elimination of CHO clonal variation allows skipping clone screenings Using enzymes called recombinases to insert genes so that cell clones behave almost identically, letting developers skip clone screening entirely.
BI Botnar Institute of Immune Engineering Basel, Switzerland
	Chair Wed Oct 14 16:45 Chair's Remarks Precision Medicine & Biomarkers Talk Thu Oct 15 09:20 Self-supervised deep learning for unbiased morphological phenotyping across cell types Training image models on unlabelled microscopy pictures so cell shapes and states can be compared across cell types without fixing the categories first. Talk Thu Oct 15 10:00 How to Accelerate Discovery with AI-assisted Automation How AI helps lab scientists build automated experiments themselves, where it still causes friction, and which vaccine and immunotherapy work it speeds up.
Indian Institute of Technology Delhi New Delhi, India
	Talk Tue Oct 13 17:50 From CFD to Digital Twins: Modeling Temperature-Driven Oxygen Transfer in Aerated Bioreactors Upstream Processing Talk Wed Oct 14 17:50 Title TBA Disease Areas: Neurodegenerative & CNS
University of Zurich Zurich, Switzerland
	Keynote Tue Oct 13 11:30 Targeting tumors directly and indirectly, using engineered vector systems Immunotherapy Keynotes Talk Thu Oct 15 10:00 Canine Cancer Immunotherapy: From Immune Profiling to Checkpoint Blockade and Real World Clinical Challenges Using pet dogs with naturally occurring cancer to study tumour immunity, starting with a flow cytometry panel for profiling canine immune cells.
University Hospital Basel Basel, Switzerland
	Chair Tue Oct 13 14:05 Chair's Remarks AI & Computational Approaches Chair Tue Oct 13 14:05 Chair's Remarks AI & Computational Approaches Talk Tue Oct 13 16:50 Building cross-border AI-ready data infrastructure and next-generation clinical trials AI & Computational Approaches Chair Thu Oct 15 08:55 Chair's Remarks Targeting the Tumor Microenvironment
University of Lausanne Lausanne, Switzerland
	Talk Tue Oct 13 14:10 Development of next-generation T cell engineering strategies targeting solid tumors Cell Therapy Chair Tue Oct 13 16:45 Chair's Remarks Cell Therapy Chair Wed Oct 14 14:05 Chair's Remarks Gene Therapy Talk Wed Oct 14 15:30 A Versatile Gene Engineering Platform for Multifunctional Cell Therapies One viral vector that adds a protein and turns down other genes, used to make donor CAR-T cells for blood and sarcoma cancers.
CSEM Neuchâtel, Switzerland
	Panel Tue Oct 13 15:10 Panel Discussion: From Research to GMP: Making MSC Manufacturing Reproducible at Scale How to grow mesenchymal stromal cells, a kind of stem cell, the same way batch after batch as production scales up. with Novartis, HINA Bioventures, Corning Life Sciences Talk Thu Oct 15 12:00 A novel 4-in-1 formulation liquid handler for high-throughput screening One automated liquid handler that mixes, measures viscosity and wetting, so formulation screening runs on tiny samples without moving them between machines. Talk Thu Oct 15 12:00 Integrating multiparameter PAT sensors with smart labware to enable high-throughput, upstream microbioreactor screening tools Manufacturing · with imec
FHNW
	Chair Tue Oct 13 16:45 Chair's Remarks AI & Computational Approaches Talk Tue Oct 13 17:10 AI Methods to Detect Dengue-Specific Immune Sequence Patterns and for Nanobody Design AI & Computational Approaches Chair Thu Oct 15 08:55 Chair's Remarks AI & Computational Approaches
BOKU University Vienna, Austria
	Talk Wed Oct 14 12:10 Purification of Recombinant Pharmaceutical Proteins from Complex Feedstocks Downstream Processing Talk Wed Oct 14 14:50 Platform process for downstream processing of viral gene therapy vectors and vaccines How viral gene therapy vectors and vaccines are purified after production, and how the viruses' size and physical traits matter.
CEA
	Talk Thu Oct 15 09:00 Fine-tuning Affinity and Selectivity of an anti- PD-L1 Antibody through Deep Learning-guided affinity maturation AI & Computational Approaches Talk Thu Oct 15 11:40 Unraveling CD4 T-Cell Responses to Therapeutic Antibodies through TCR Sequencing: A Novel Approach to Immunogenicity Risk Assessment Immunogenicity